N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide

C26H26N6O3S — CID 74982598

IUPACN-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide
SMILESO=C(Cc1ccccc1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3cccc(O)c3)s2)nn1
InChIInChI=1S/C26H26N6O3S/c33-21-11-6-9-19(15-21)17-24(35)28-26-32-31-25(36-26)12-5-4-10-20-13-14-22(30-29-20)27-23(34)16-18-7-2-1-3-8-18/h1-3,6-9,11,13-15,33H,4-5,10,12,16-17H2,(H,27,30,34)(H,28,32,35)
InChIKeyIHLDZSVHYJEXBF-UHFFFAOYSA-N
MW502.60 g/mol
LogP3.96
Rot. Bonds11

About N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide

N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide (PubChem CID 74982598) has the molecular formula C26H26N6O3S and a molecular weight of 502.60 g/mol. Its IUPAC name is N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide.

Molecular Properties

Compound NameN-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide
PubChem CID74982598
Molecular FormulaC26H26N6O3S
Molecular Weight502.60 g/mol
Exact Mass502.18
IUPAC NameN-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide
SMILESO=C(Cc1ccccc1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3cccc(O)c3)s2)nn1
InChIInChI=1S/C26H26N6O3S/c33-21-11-6-9-19(15-21)17-24(35)28-26-32-31-25(36-26)12-5-4-10-20-13-14-22(30-29-20)27-23(34)16-18-7-2-1-3-8-18/h1-3,6-9,11,13-15,33H,4-5,10,12,16-17H2,(H,27,30,34)(H,28,32,35)
InChIKeyIHLDZSVHYJEXBF-UHFFFAOYSA-N
XLogP3.96
TPSA129.99 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds11
Heavy Atoms36
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500502.60
LogP ≤ 53.96
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide?
The IUPAC name of N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide (CID 74982598) is N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide.
What is the SMILES notation for N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide?
The canonical SMILES for N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide is O=C(Cc1ccccc1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3cccc(O)c3)s2)nn1.
What is the InChIKey of N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide?
The InChIKey is IHLDZSVHYJEXBF-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H26N6O3S/c33-21-11-6-9-19(15-21)17-24(35)28-26-32-31-25(36-26)12-5-4-10-20-13-14-22(30-29-20)27-23(34)16-18-7-2-1-3-8-18/h1-3,6-9,11,13-15,33H,4-5,10,12,16-17H2,(H,27,30,34)(H,28,32,35).
What are the key properties of N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide?
N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide has a molecular weight of 502.60 g/mol, XLogP of 3.96, 11 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-[4-[5-[[2-(3-hydroxyphenyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-phenylacetamide is sourced from PubChem (CID 74982598), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).